Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1994 1
1995 1
1996 2
1997 2
1998 2
2002 2
2007 1
2008 1
2010 2
2011 1
2012 1
2013 6
2014 1
2015 1
2016 3
2017 1
2019 1
2020 2
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Ovarian Transitional Cell Carcinoma"
Page 1
Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.
Lin DI, Fine A, Danziger NA, Huang RSP, Mata DA, Decker B, Killian JK, Ramkissoon SH, Lechpammer M, Janovitz T, Ross JS, Sokol ES, Elvin JA. Lin DI, et al. Gynecol Oncol. 2022 Mar;164(3):558-565. doi: 10.1016/j.ygyno.2021.12.030. Epub 2022 Jan 5. Gynecol Oncol. 2022. PMID: 34998597
Evidence of homologous recombination deficiency (HRD) was determined via genomic loss of heterozygosity (gLOH), a validated HRD detection method for predicting PARP inhibitor effectiveness in ovarian carcinoma. High gLOH was defined as 16%. ...BRCA1 and BRCA2 …
Evidence of homologous recombination deficiency (HRD) was determined via genomic loss of heterozygosity (gLOH), a validated HRD detection me …
Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED, Marques-Piubelli ML, Ramalingam P, Wistuba I, Lawson BC, Frumovitz M, Malpica A. Euscher ED, et al. Am J Surg Pathol. 2023 Jun 1;47(6):635-648. doi: 10.1097/PAS.0000000000002039. Epub 2023 Apr 6. Am J Surg Pathol. 2023. PMID: 37026792
Extrauterine mesonephric-like carcinoma (ExUMLC) shares histologic, immunohistochemical (IHC), and molecular (MOL) features with endometrial mesonephric-like carcinoma (EnMLC). ...Twenty-one ExUMLC (63%) had associated endometriosis, and 7 (21%) arose in a borderlin …
Extrauterine mesonephric-like carcinoma (ExUMLC) shares histologic, immunohistochemical (IHC), and molecular (MOL) features with endo …
Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
Lin DI, Killian JK, Venstrom JM, Ramkissoon SH, Ross JS, Elvin JA. Lin DI, et al. Mod Pathol. 2021 May;34(5):983-993. doi: 10.1038/s41379-020-00699-1. Epub 2020 Oct 19. Mod Pathol. 2021. PMID: 33077920 Free article.
At the time of molecular profiling, there was no evidence of a primary urothelial carcinoma of the urinary tract in any case. Cases with transitional-like morphologic features in the setting of variant ovarian serous or endometrioid carcinoma morpholog …
At the time of molecular profiling, there was no evidence of a primary urothelial carcinoma of the urinary tract in any case. Cases w …
Papillary squamotransitional cell carcinoma of the uterine cervix: a case report and review of the literature.
Gitas G, Ertan K, Rody A, Baum S, Tsolakidis D, Alkatout I. Gitas G, et al. J Med Case Rep. 2019 Oct 27;13(1):319. doi: 10.1186/s13256-019-2217-2. J Med Case Rep. 2019. PMID: 31655625 Free PMC article. Review.
BACKGROUND: Papillary squamotransitional cell carcinoma of the uterine cervix is a rare neoplasm, a subtype of transitional cervical carcinoma that appears to be a variation of squamous cervical carcinoma. ...Physicians should always contemplate …
BACKGROUND: Papillary squamotransitional cell carcinoma of the uterine cervix is a rare neoplasm, a subtype of transitional
Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer.
Mackay HJ, Brady MF, Oza AM, Reuss A, Pujade-Lauraine E, Swart AM, Siddiqui N, Colombo N, Bookman MA, Pfisterer J, du Bois A; Gynecologic Cancer InterGroup. Mackay HJ, et al. Int J Gynecol Cancer. 2010 Aug;20(6):945-52. doi: 10.1111/IGC.0b013e3181dd0110. Int J Gynecol Cancer. 2010. PMID: 20683400 Review.
RESULTS: Data on 8704 women with stage III/IV EOC from 7 randomized trials were included in these analyses. Two hundred twenty-one patients (2.5%) had clear cell carcinoma; 264 (3.0%), mucinous; and 36 (0.4%), transitional cell. ...CONCLUSIONS: Mucinou …
RESULTS: Data on 8704 women with stage III/IV EOC from 7 randomized trials were included in these analyses. Two hundred twenty-one patients …
Prognostic value of CA 125 in transitional cell carcinoma of the bladder.
Manvar AM, Wallen EM, Pruthi RS, Nielsen ME. Manvar AM, et al. Expert Rev Anticancer Ther. 2010 Dec;10(12):1877-81. doi: 10.1586/era.10.186. Expert Rev Anticancer Ther. 2010. PMID: 21110754
Conventionally utilized for the management of ovarian cancer, the ability to detect CA 125 in transitional cell carcinoma tissue and urine of patients with transitional cell carcinoma raises the possibility that bladder cancer may …
Conventionally utilized for the management of ovarian cancer, the ability to detect CA 125 in transitional cell carc
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
Pfarr N, Darb-Esfahani S, Leichsenring J, Taube E, Boxberg M, Braicu I, Jesinghaus M, Penzel R, Endris V, Noske A, Weichert W, Schirmacher P, Denkert C, Stenzinger A. Pfarr N, et al. Genes Chromosomes Cancer. 2017 Oct;56(10):758-766. doi: 10.1002/gcc.22480. Epub 2017 Jul 25. Genes Chromosomes Cancer. 2017. PMID: 28639280
We employed targeted next generation sequencing to analyze the mutational landscape in a cohort of 23 BT cases (17 benign, 2 borderline, and 4 malignant) and 3 ovarian carcinomas with transitional cell histology (TCC). Copy number variations (CNV) were valida …
We employed targeted next generation sequencing to analyze the mutational landscape in a cohort of 23 BT cases (17 benign, 2 borderline, and …
Image cytometric analysis in pathology.
Cohen C. Cohen C. Hum Pathol. 1996 May;27(5):482-93. doi: 10.1016/s0046-8177(96)90091-x. Hum Pathol. 1996. PMID: 8621187
On bladder washings, DNA ploidy by ICM is used as an aid in diagnosis and management of recurrent transitional cell carcinoma of the bladder. Quantitation of nuclear immunostain for proliferation markers by ICM has clinical significance in prognosis
On bladder washings, DNA ploidy by ICM is used as an aid in diagnosis and management of recurrent transitional cell
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA, Ashfaq R, Albores-Saavedra J, Tavassoli FA. Lininger RA, et al. Cancer. 1997 May 15;79(10):1933-43. Cancer. 1997. PMID: 9149020
BACKGROUND: Transitional cell carcinoma (TCC) is rare in the female genital tract. ...Of five women for whom follow-up was available, three were alive with no evidence of disease, one was alive with a local recurrence, and one died of unrelated disease …
BACKGROUND: Transitional cell carcinoma (TCC) is rare in the female genital tract. ...Of five women for whom follow-up …
Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4).
Costa MJ, Hansen C, Dickerman A, Scudder SA. Costa MJ, et al. Am J Clin Pathol. 1998 Feb;109(2):173-80. doi: 10.1093/ajcp/109.2.173. Am J Clin Pathol. 1998. PMID: 9583889
The transitional cell carcinoma (TCC) pattern has been associated with favorable outcome in patients with late-stage ovarian epithelial tumors who receive chemotherapy. ...The other predominant histopathologic types were serous (65.4%), mucinous (11.7% …
The transitional cell carcinoma (TCC) pattern has been associated with favorable outcome in patients with late-stage …
35 results